-
Anti-DYKDDDDK (Flag) Magnetic Beads Guide
2026-09-30
Anti-DYKDDDDK (Flag) Magnetic Beads selectively capture DYKDDDDK (Flag)-tagged fusion proteins from clarified lysates for small-scale purification, immunoprecipitation, and co-immunoprecipitation. They are intended for accessible Flag-tagged targets, not tag-free proteins, nonspecific enrichment, or unvalidated high-throughput workflows.
-
COMET: Transformer Design of Lipid Nanoparticles
2026-09-29
The reference study introduces COMET, a transformer-based neural network that represents complete lipid nanoparticle formulations rather than optimizing individual lipids in isolation. Trained on the LANCE dataset, COMET predicted formulation performance, supported virtual screening, and transferred to non-canonical formulations, additional cell contexts, and lyophilization-related stability tasks.
-
ABCC10, cGAMP Efflux, and Radiotherapy Resistance
2026-09-29
The reference study identifies ABCC10 as an ATP-dependent exporter of 2'3'-cGAMP and links this transport activity to suppression of intracellular STING-TBK1-IRF3 signaling during radiotherapy. Its findings connect nucleotide transport with radioresistance and suggest that ABCC10 may serve as both a response biomarker and a therapeutic target, although the broader consequences of cGAMP redistribution remain context dependent.
-
SDF-1beta (CXCL12) for Brucella Assays
2026-09-28
Explore how SDF-1beta (CXCL12), human recombinant can be used to ask focused questions about chemokine signaling in macrophage assays. This article separates established findings from a Brucella CRISPR screen from testable hypotheses, then translates that distinction into practical experimental design.
-
Staurosporine in Matrix-Aware Apoptosis Assays
2026-09-27
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor often used to induce apoptosis, but cell-matrix context can reshape how those responses should be interpreted. This article connects Staurosporine-based assay design with recent evidence on tumor-restrictive type III collagen in breast cancer.
-
Deferasirox Fe3+ Chelate: Research Workflows
2026-09-26
Use Deferasirox Fe3+ chelate as a defined ferric complex for iron-speciation controls and ligand-exchange experiments—not as a stand-in for free deferasirox. This workflow guide covers solvent handling, assay design, and the key distinction between a research reagent and clinical Exjade therapy.
-
Mitoxantrone: Reading Potency Through ABCG2
2026-09-26
Mitoxantrone response reflects both topoisomerase II activity and how much drug reaches the cell. This article explains how ABCG2 research changes interpretation of Mitoxantrone sensitivity and guides exposure-aware experiments.
-
Molecular Basis of TRPM3 Modulation by Ligands
2026-09-25
Yin and colleagues combine cryo-EM structures with electrophysiology, molecular dynamics, and biochemical analyses to map how pregnenolone sulfate, CIM 0216, and primidone interact with TRPM3. The results connect ligand recognition to channel regulation and provide a structural framework for studying TRPM3-related pain and neurodevelopmental disease, while leaving important questions about physiological context and therapeutic selectivity open.
-
Tranexamic Acid for Fibrinolysis Research
2026-09-25
Use Tranexamic Acid to probe clot stability, plasmin-dependent cell interactions, and antifibrinolytic performance in controlled research workflows. A recent wound-dressing study offers a distinct biomaterials use-case, while practical assay guidance helps separate TXA’s clot-preserving contribution from other dressing components.
-
Deferasirox Fe3+ Chelate: Assay Workflow Guide
2026-09-24
A practical guide to using Deferasirox Fe3+ chelate (SKU A3355) in cell-based iron-overload research, with attention to chemical form, solvent compatibility, and assay interpretation. It separates documented product specifications from workflow recommendations and highlights controls needed for defensible viability data.
-
Ferrostatin-1: From Mechanism to Translational Strategy
2026-09-24
Ferrostatin-1 (Fer-1) can help researchers test whether lipid peroxidation contributes to cell injury—but a rescue result is most informative when paired with orthogonal readouts and clear mechanistic boundaries. This article connects ferroptosis assay design with evidence on Kupffer-cell membrane repair, without treating distinct injury processes as interchangeable.
-
A Multimodal iPSC Platform for Cystic Fibrosis Testing
2026-09-23
The study establishes an induced pluripotent stem cell (iPSC)-derived airway platform that combines three-dimensional spheroid swelling and polarized airway culture assays to examine CFTR function across common and rare cystic fibrosis variants. Its central contribution is a human-cell approach for detecting genotype-specific baseline function and modulator responses, with potential value for investigating variants that are poorly served by current therapies.
-
Ridaforolimus: An Evidence-First mTOR Assay Strategy
2026-09-22
Ridaforolimus and Deforolimus provide a precise way to interrogate mTOR-dependent growth, signaling, and VEGF production. This evidence-first guide connects robust cancer assays with the validation logic required for senescence and senolytic research.
-
Radioiodinated Balsalazide for Ulcerative Colitis Imaging
2026-09-22
The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for ulcerative colitis in mice. Optimized labeling conditions, 24-hour stability, and preferential accumulation in ulcerated colon support its use as a preclinical imaging tool, while species, isotope, and mechanism limitations constrain direct clinical translation.
-
Halazone Workflows for Water and Nerve Assays
2026-09-21
Halazone supports two highly differentiated research workflows: rapid oxidative water disinfection and controlled studies of sodium-current inactivation in myelinated nerve fibers. This practical guide connects concentration, redox, temperature, exposure time, and solution stability to reproducible bench decisions.